Literature DB >> 16109997

Bupivacaine induces apoptosis via ROS in the Schwann cell line.

C J Park1, S A Park, T G Yoon, S J Lee, K W Yum, H J Kim.   

Abstract

Local anesthetics have been generally accepted as being safe. However, recent clinical trials and basic studies have provided strong evidence for the neurotoxicity of local anesthetics, especially through apoptosis. We hypothesized that local anesthetics cause neural complications through Schwann cell apoptosis. Among local anesthetics tested on the Schwann cell line, RT4-D6P2T, bupivacaine significantly induced cell death, measured by the methyl tetrazolium (MTT) assay, in a dose- (LD50 = 476 microM) and time-dependent manner. The bupivacaine-induced generation of reactive oxygen species (ROS), which was initiated within 5 hrs and preceded the activation of caspase-3 and poly ADP-ribose polymerase (PARP) degradation, was suggested to trigger apoptosis, exhibited by Hoechst 33258 nuclear staining and DNA fragmentation. Furthermore, concomitant block of ROS by anti-oxidants significantly inhibited bupivacaine-induced apoptosis. Among the local anesthetics for peripheral neural blocks, bupivacaine induced apoptosis in the Schwann cell line, which may be associated with ROS production.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16109997     DOI: 10.1177/154405910508400914

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  28 in total

1.  Cartilage toxicity from local anesthetics.

Authors:  Ravi Kamath; Gary Strichartz; Daniel Rosenthal
Journal:  Skeletal Radiol       Date:  2008-10       Impact factor: 2.199

2.  In vitro exposure of human fibroblasts to local anaesthetics impairs cell growth.

Authors:  C Fedder; B Beck-Schimmer; J Aguirre; M Hasler; B Roth-Z'graggen; M Urner; S Kalberer; A Schlicker; G Votta-Velis; J M Bonvini; K Graetz; A Borgeat
Journal:  Clin Exp Immunol       Date:  2010-09-01       Impact factor: 4.330

3.  Neuroprotection by epigallo catechin gallate against bupivacaine anesthesia induced toxicity involves modulation of PI3/Akt/PTEN signalling in N2a and SH-SY5Y cells.

Authors:  Li-Yan Wang; Xia Li; Yu-Zeng Han
Journal:  Int J Clin Exp Med       Date:  2015-09-15

4.  Local anesthetic Schwann cell toxicity is time and concentration dependent.

Authors:  Sufang Yang; Matthew S Abrahams; Patricia D Hurn; Marjorie R Grafe; Jeffrey R Kirsch
Journal:  Reg Anesth Pain Med       Date:  2011 Sep-Oct       Impact factor: 6.288

5.  Bupivacaine causes cytotoxicity in mouse C2C12 myoblast cells: involvement of ERK and Akt signaling pathways.

Authors:  Joseph M Maurice; Yan Gan; Fan-xin Ma; Yong-chang Chang; Michael Hibner; Yao Huang
Journal:  Acta Pharmacol Sin       Date:  2010-03-15       Impact factor: 6.150

6.  The in vitro effects of bupivacaine on articular chondrocytes.

Authors:  C R Chu; N J Izzo; C H Coyle; N E Papas; A Logar
Journal:  J Bone Joint Surg Br       Date:  2008-06

7.  Nicotinamide adenine dinucleotide (NAD+) repletion attenuates bupivacaine-induced neurotoxicity.

Authors:  Ting Zheng; Shi Yuan Xu; Shu Qin Zhou; Lu Ying Lai; Le Li
Journal:  Neurochem Res       Date:  2013-07-02       Impact factor: 3.996

8.  Increased Oxidative Damage and Reduced DNA Repair Enzyme XPD Involvement in High Glucose-Mediated Enhancement of Levobupivacaine-Induced Neurotoxicity.

Authors:  ZhongJie Liu; Wei Zhao; QingGuo Zhang; LuYing Lai; Shan Jiang; Jing Zhang; ShiYuan Xu
Journal:  Neurochem Res       Date:  2015-08-12       Impact factor: 3.996

9.  Downregulation of miR-210 protected bupivacaine-induced neurotoxicity in dorsal root ganglion.

Authors:  Yiheng Wang; Hongxia Ni; Wenrui Zhang; Xiu Wang; Haishan Zhang
Journal:  Exp Brain Res       Date:  2015-12-26       Impact factor: 1.972

10.  Oxidative modulation of marcaine and lekoptin in H9C2 rat myoblasts.

Authors:  Julita Kulbacka; Julita Bar; Agnieszka Chwilkowska; Malgorzata Dumanska; Malgorzata Drag-Zalesinska; Teresa Wysocka; Kamilla Stach; Iwona Bednarz; Mateusz Lugowski; Anna Marcinkowska; Andrzej Gamian; Jolanta Saczko
Journal:  Acta Pharmacol Sin       Date:  2009-02       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.